NDC 70651-001

Pentetate calcium trisodium

Pentetate Calcium Trisodium

Pentetate calcium trisodium is a Intravenous; Respiratory (inhalation) Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Hameln Pharma Gmbh. The primary component is Pentetate Calcium Trisodium.

Product ID70651-001_1b3410c5-6dba-401e-8a6e-4b483e65dc48
NDC70651-001
Product TypeHuman Prescription Drug
Proprietary NamePentetate calcium trisodium
Generic NamePentetate Calcium Trisodium
Dosage FormInjection, Solution, Concentrate
Route of AdministrationINTRAVENOUS; RESPIRATORY (INHALATION)
Marketing Start Date2004-08-11
Marketing End Date2026-05-31
Marketing CategoryNDA / NDA
Application NumberNDA021749
Labeler Namehameln pharma gmbh
Substance NamePENTETATE CALCIUM TRISODIUM
Active Ingredient Strength1000 mg/5mL
Pharm ClassesLead Chelating Activity [MoA],Lead Chelator [EPC]
NDC Exclude FlagN

Packaging

NDC 70651-001-03

10 AMPULE in 1 PACKAGE (70651-001-03) > 5 mL in 1 AMPULE
Marketing Start Date2004-08-11
Marketing End Date2026-05-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70651-001-03 [70651000103]

Pentetate calcium trisodium INJECTION, SOLUTION, CONCENTRATE
Marketing CategoryNDA
Application NumberNDA021749
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2004-08-11

Drug Details

Active Ingredients

IngredientStrength
PENTETATE CALCIUM TRISODIUM1000 mg/5mL

OpenFDA Data

SPL SET ID:bc563e90-10e5-475d-aa84-b0e3d582ae95
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 413287
  • Pharmacological Class

    • Lead Chelating Activity [MoA]
    • Lead Chelator [EPC]

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.